APP, amyloid beta precursor protein, 351

N. diseases: 485; N. variants: 114
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0751262
Disease: Adult Learning Disorders
Adult Learning Disorders
0.300 Biomarker group CTD_human Virgin coconut oil (VCO) by normalizing NLRP3 inflammasome showed potential neuroprotective effects in Amyloid-β induced toxicity and high-fat diet fed rat. 29729307 2018
CUI: C0751262
Disease: Adult Learning Disorders
Adult Learning Disorders
0.300 Biomarker group CTD_human [Gly14]-Humanin Protects Against Amyloid β Peptide-Induced Impairment of Spatial Learning and Memory in Rats. 27306655 2016
CUI: C0751262
Disease: Adult Learning Disorders
Adult Learning Disorders
0.300 Biomarker group CTD_human Ethosuximide Induces Hippocampal Neurogenesis and Reverses Cognitive Deficits in an Amyloid-β Toxin-induced Alzheimer Rat Model via the Phosphatidylinositol 3-Kinase (PI3K)/Akt/Wnt/β-Catenin Pathway. 26420483 2015
CUI: C0751262
Disease: Adult Learning Disorders
Adult Learning Disorders
0.300 Biomarker group CTD_human Notoginsenoside R1 increases neuronal excitability and ameliorates synaptic and memory dysfunction following amyloid elevation. 25213453 2014
CUI: C0751262
Disease: Adult Learning Disorders
Adult Learning Disorders
0.300 Biomarker group CTD_human Protective effects of astragalosides on dexamethasone and Aβ25-35 induced learning and memory impairments due to decrease amyloid precursor protein expression in 12-month male rats. 22484447 2012
CUI: C0751262
Disease: Adult Learning Disorders
Adult Learning Disorders
0.300 Biomarker group CTD_human Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-β(1-40) administration in mice: evidence for dissociation between cognitive deficits and neuronal damage. 20816828 2010
CUI: C0751262
Disease: Adult Learning Disorders
Adult Learning Disorders
0.300 Biomarker group CTD_human Hyposensitivity to the amnesic effects of scopolamine or amyloid beta(25-35) peptide in heterozygous acetylcholinesterase knockout (AChE(+/-)) mice. 18533140 2008
CUI: C0751262
Disease: Adult Learning Disorders
Adult Learning Disorders
0.300 Biomarker group CTD_human Effects of a novel cognitive enhancer, spiro[imidazo-[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446), on learning impairments induced by amyloid-beta1-40 in the rat. 16474004 2006